Infections & immunity
The Infections and Immunity Board (IIB) is responsible for the MRC’s investments in infectious human disease and disorders of the human immune system. This includes and is underpinned by fundamental research into human pathogens, as well as the normal development and functioning of the human immune system, which informs mechanism of disease.
The Board’s strategy includes extending its global health activities, addressing the challenge of antimicrobial resistance, strengthening pandemic preparedness, investigating immunity and infection through the life course, and supporting data integrative and systems approaches.
To deliver its strategy, the Board supports investigator-led grants within its area of remit, and manages a range of strategic investments and partnerships.